エクソソーム診断・治療の世界市場：市場規模・予測 - 用途別、製品別、エンドユーザー別、地域別分析、2023～2030年

世界のエクソソーム診断・治療の市場規模は、2022年に約3億7,564万米ドルに達し、2023～2030年の予測期間中にかけ29.4%以上の健全な成長率で推移すると予測されています。

エクソソーム診断・治療とは、細胞から分泌される小さな膜小胞であるエクソソームを、様々な医療用途における診断・治療目的で使用することを指します。エクソソームには、タンパク質、核酸（DNA、RNA、マイクロRNAなど）、脂質、代謝産物などさまざまな生体分子が含まれており、これらは親細胞の生理学的・病理学的状態を反映しています。エクソソームは、様々な疾患の診断や予後のための貴重なバイオマーカーとして機能します。エクソソームは血液、尿、唾液などの体液中に放出されるため、診断情報を得るための非侵襲的な方法を提供します。エクソソーム診断・治療市場は、慢性疾患の有病率の増加や分子診断の需要の急増などの要因により拡大しています。その結果、2023～2030年の予測期間中、エクソソーム診断・治療に対する需要は国際市場で徐々に増加しています。

慢性疾患はしばしば、効果的な管理のために早期発見と継続的なモニタリングを必要とします。エクソソームは、その起源細胞を反映する分子シグネチャーを含み、タンパク質、核酸、脂質などの生体分子を運びます。エクソソームの含有量を分析することにより、臨床医は従来の方法よりも早期に疾患特異的バイオマーカーを検出することができ、タイムリーな介入や疾患の進行のモニタリングが可能になります。国連の報告書によると、慢性疾患は世界の死亡者数の70％を占め、2030年には世界の疾病負担は56％になると予測されています。アフリカと東地中海地域で最も大きな成長が見込まれています。さらに、エクソソーム生物学と疾患発症におけるその役割についての理解が深まるにつれ、エクソソーム診断・治療領域における研究開発に大きな拍車がかかっています。これには、エクソソームバイオマーカーの発見、高度な分離・検出技術の開発、エクソソームに基づく治療法の探求などが含まれます。エクソソーム診断・治療市場を牽引するもう一つの重要な要因は、分子診断に対する需要の高まりです。分子診断により、分子レベルでの疾患のより正確な理解が可能になり、個別化された治療戦略が可能になります。エクソソームは細胞から放出される微小な小胞で、親細胞の状態を反映する貴重な分子情報を運ぶ。タンパク質、核酸、脂質を含むエクソソームの内容物を分析することで、分子診断が可能になり、がん、感染症、神経疾患など、さまざまな病気を示す特定のバイオマーカーの検出が容易になります。さらに、フロンティアオーガニゼーションによれば、幹細胞由来のエクソソームには、細胞増殖や組織治癒を刺激する成長因子やシグナル伝達分子が含まれています。エクソソームに基づく治療法は、心臓病や組織損傷などの症状に対して研究されています。さらに、医薬品開発におけるエクソソーム技術の高度化と、トランスレーショナルプレシジョンメディシンの進展は、予測期間中、市場に有利な成長機会をもたらすと予想されます。しかし、エクソソームベースの治療薬の高い開発コストと医薬品承認に向けた政府の厳しい規制は、2023～2030年の予測期間を通じて市場全体の成長を阻害することになるでしょう。

世界のエクソソーム診断・治療市場調査において考慮した主要地域は、アジア太平洋、北米、欧州、ラテンアメリカ、中東・アフリカです。北米は、同地域における慢性疾患の流行により、2022年の市場を独占しました。米国疾病予防管理センターによると、米国では成人10人中6人が慢性疾患を患っています。慢性疾患を効果的に管理するには、早期発見と継続的なモニタリングが必要な場合が多いです。エクソソームに基づく診断法は、がん、心血管疾患、神経疾患などの疾患の早期発見のための非侵襲的で高感度な方法を提供します。これらの診断により、ヘルスケアプロバイダーは疾患の早期段階で介入することが可能となり、患者の予後改善につながります。この地域の圧倒的な実績は、エクソソーム診断・治療薬全体の需要を促進すると予想されます。さらに、アジア太平洋地域は、同地域におけるヘルスケア支出の増加などの要因により、予測期間中に最も急成長すると予想されます。ヘルスケア支出の増加は、病院、研究施設、診断研究所などのヘルスケアインフラの拡張と近代化につながることが多いです。このようなインフラの拡大は、エクソソームに基づく診断薬や治療薬の開発、試験、商業化に必要な資源や施設を提供することができます。

本調査の目的は、近年におけるさまざまなセグメントと国の市場規模を明らかにし、今後数年間の値を予測することです。本レポートは、調査対象国における産業の質的・量的側面を取り入れるよう設計されています。

また、市場の将来的な成長を規定する促進要因や課題など、重要な側面に関する詳細情報も掲載しています。さらに、主要企業の競合情勢や製品提供の詳細な分析とともに、利害関係者が投資するためのミクロ市場における潜在的な機会も組み込んでいます。

目次

第1章 エグゼクティブサマリー

第2章 世界のエクソソーム診断・治療市場の定義と範囲

• 調査目的
• 市場の定義と範囲
  • 産業の進化
  • 調査範囲
• 調査対象年
• 通貨換算レート

第3章 世界のエクソソーム診断・治療の市場力学

• エクソソーム診断・治療市場の影響分析（2020～2030年）
  • 市場促進要因
    • 慢性疾患の有病率の増加
    • 分子診断の需要急増
  • 市場の課題
    • エクソソームベース治療薬の高い開発コスト
    • 医薬品承認に関する政府の厳しい規制
  • 市場機会
    • 医薬品開発における先進的エクソソーム技術の統合
    • トランスレーショナルプレシジョンメディシンの進展

第4章 世界のエクソソーム診断・治療市場の産業分析

• ポーターのファイブフォースモデル
  • 供給企業の交渉力
  • 買い手の交渉力
  • 新規参入業者の脅威
  • 代替品の脅威
  • 競争企業間の敵対関係
• ポーターのファイブフォース影響分析
• PEST分析
  • 政治
  • 経済
  • 社会
  • 技術
  • 環境
  • 法律
• 主な投資機会
• 主要成功戦略
• COVID-19影響分析
• 破壊的動向
• 産業専門家の視点
• アナリストの結論・提言

第5章 エクソソーム診断・治療の世界市場：用途別

• 市場スナップショット
• エクソソーム診断・治療の世界市場：用途別、実績 - ポテンシャル分析
• エクソソーム診断・治療の世界市場：用途別、推定・予測、2020～2030年
• エクソソーム診断・治療市場、サブセグメント分析
  • 診断
  • 治療

第6章 エクソソーム診断・治療の世界市場：製品別

• 市場スナップショット
• エクソソーム診断・治療の世界市場：製品別、実績 - ポテンシャル分析
• エクソソーム診断・治療の世界市場：製品別、推定・予測、2020～2030年
• エクソソーム診断・治療市場、サブセグメント分析
  • 機器
  • 試薬
  • ソフトウェア

第7章 エクソソーム診断・治療の世界市場：エンドユーザー別

• 市場スナップショット
• エクソソーム診断・治療の世界市場：エンドユーザー別、実績 - ポテンシャル分析
• エクソソーム診断・治療の世界市場：エンドユーザー別、推定・予測、2020～2030年
• エクソソーム診断・治療市場、サブセグメント分析
  • がん研究所
  • 病院
  • 診断センター
  • その他

第8章 エクソソーム診断・治療の世界市場：地域別分析

• 主要国
• 主な新興国
• エクソソーム診断・治療市場、地域別市場スナップショット
• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • スペイン
  • イタリア
  • その他の欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • オーストラリア
  • 韓国
  • その他のアジア太平洋
• ラテンアメリカ
  • ブラジル
  • メキシコ
• 中東・アフリカ
  • サウジアラビア
  • 南アフリカ
  • その他の中東・アフリカ

第9章 競合情報

• 主要企業のSWOT分析
• 主要市場戦略
• 企業プロファイル
  • Malvern Instruments Limited
  • System Biosciences Incorporated
  • Exiqon A/S
  • Capricor Therapeutics, Inc.
  • NanoSomix, Inc.
  • Thermo Fisher Scientific Incorporated
  • Sistemic Limited
  • Exosome Diagnostic, Inc.
  • NX Pharmagen, Inc.
  • Aethlon Medical, Inc

第10章 調査プロセス

LIST OF TABLES

• TABLE 1.Global Exosome Diagnostic and Therapeutic Market, report scope
• TABLE 2.Global Exosome Diagnostic and Therapeutic Market estimates & forecasts by Region 2020-2030 (USD Million)
• TABLE 3.Global Exosome Diagnostic and Therapeutic Market estimates & forecasts by Application 2020-2030 (USD Million)
• TABLE 4.Global Exosome Diagnostic and Therapeutic Market estimates & forecasts by Product 2020-2030 (USD Million)
• TABLE 5.Global Exosome Diagnostic and Therapeutic Market estimates & forecasts by End User 2020-2030 (USD Million)
• TABLE 6.Global Exosome Diagnostic and Therapeutic Market by segment, estimates & forecasts, 2020-2030 (USD Million)
• TABLE 7.Global Exosome Diagnostic and Therapeutic Market by region, estimates & forecasts, 2020-2030 (USD Million)
• TABLE 8.Global Exosome Diagnostic and Therapeutic Market by segment, estimates & forecasts, 2020-2030 (USD Million)
• TABLE 9.Global Exosome Diagnostic and Therapeutic Market by region, estimates & forecasts, 2020-2030 (USD Million)
• TABLE 10.Global Exosome Diagnostic and Therapeutic Market by segment, estimates & forecasts, 2020-2030 (USD Million)
• TABLE 11.Global Exosome Diagnostic and Therapeutic Market by region, estimates & forecasts, 2020-2030 (USD Million)
• TABLE 12.Global Exosome Diagnostic and Therapeutic Market by segment, estimates & forecasts, 2020-2030 (USD Million)
• TABLE 13.Global Exosome Diagnostic and Therapeutic Market by region, estimates & forecasts, 2020-2030 (USD Million)
• TABLE 14.Global Exosome Diagnostic and Therapeutic Market by segment, estimates & forecasts, 2020-2030 (USD Million)
• TABLE 15.Global Exosome Diagnostic and Therapeutic Market by region, estimates & forecasts, 2020-2030 (USD Million)
• TABLE 16.U.S. Exosome Diagnostic and Therapeutic Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 17.U.S. Exosome Diagnostic and Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 18.U.S. Exosome Diagnostic and Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 19.Canada Exosome Diagnostic and Therapeutic Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 20.Canada Exosome Diagnostic and Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 21.Canada Exosome Diagnostic and Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 22.UK Exosome Diagnostic and Therapeutic Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 23.UK Exosome Diagnostic and Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 24.UK Exosome Diagnostic and Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 25.Germany Exosome Diagnostic and Therapeutic Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 26.Germany Exosome Diagnostic and Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 27.Germany Exosome Diagnostic and Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 28.France Exosome Diagnostic and Therapeutic Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 29.France Exosome Diagnostic and Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 30.France Exosome Diagnostic and Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 31.Italy Exosome Diagnostic and Therapeutic Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 32.Italy Exosome Diagnostic and Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 33.Italy Exosome Diagnostic and Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 34.Spain Exosome Diagnostic and Therapeutic Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 35.Spain Exosome Diagnostic and Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 36.Spain Exosome Diagnostic and Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 37.RoE Exosome Diagnostic and Therapeutic Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 38.RoE Exosome Diagnostic and Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 39.RoE Exosome Diagnostic and Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 40.China Exosome Diagnostic and Therapeutic Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 41.China Exosome Diagnostic and Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 42.China Exosome Diagnostic and Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 43.India Exosome Diagnostic and Therapeutic Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 44.India Exosome Diagnostic and Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 45.India Exosome Diagnostic and Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 46.Japan Exosome Diagnostic and Therapeutic Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 47.Japan Exosome Diagnostic and Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 48.Japan Exosome Diagnostic and Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 49.South Korea Exosome Diagnostic and Therapeutic Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 50.South Korea Exosome Diagnostic and Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 51.South Korea Exosome Diagnostic and Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 52.Australia Exosome Diagnostic and Therapeutic Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 53.Australia Exosome Diagnostic and Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 54.Australia Exosome Diagnostic and Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 55.RoAPAC Exosome Diagnostic and Therapeutic Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 56.RoAPAC Exosome Diagnostic and Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 57.RoAPAC Exosome Diagnostic and Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 58.Brazil Exosome Diagnostic and Therapeutic Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 59.Brazil Exosome Diagnostic and Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 60.Brazil Exosome Diagnostic and Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 61.Mexico Exosome Diagnostic and Therapeutic Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 62.Mexico Exosome Diagnostic and Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 63.Mexico Exosome Diagnostic and Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 64.RoLA Exosome Diagnostic and Therapeutic Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 65.RoLA Exosome Diagnostic and Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 66.RoLA Exosome Diagnostic and Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 67.Saudi Arabia Exosome Diagnostic and Therapeutic Market estimates & forecasts, 2020-2030 (USD Million)
• TABLE 68.South Africa Exosome Diagnostic and Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 69.RoMEA Exosome Diagnostic and Therapeutic Market estimates & forecasts by segment 2020-2030 (USD Million)
• TABLE 70.List of secondary sources, used in the study of global Exosome Diagnostic and Therapeutic Market
• TABLE 71.List of primary sources, used in the study of global Exosome Diagnostic and Therapeutic Market
• TABLE 72.Years considered for the study
• TABLE 73.Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

• FIG 1.Global Exosome Diagnostic and Therapeutic Market, research methodology
• FIG 2.Global Exosome Diagnostic and Therapeutic Market, Market estimation techniques
• FIG 3.Global Market size estimates & forecast methods
• FIG 4.Global Exosome Diagnostic and Therapeutic Market, key trends 2022
• FIG 5.Global Exosome Diagnostic and Therapeutic Market, growth prospects 2023-2030
• FIG 6.Global Exosome Diagnostic and Therapeutic Market, porters 5 force model
• FIG 7.Global Exosome Diagnostic and Therapeutic Market, pest analysis
• FIG 8.Global Exosome Diagnostic and Therapeutic Market, value chain analysis
• FIG 9.Global Exosome Diagnostic and Therapeutic Market by segment, 2020 & 2030 (USD Million)
• FIG 10.Global Exosome Diagnostic and Therapeutic Market by segment, 2020 & 2030 (USD Million)
• FIG 11.Global Exosome Diagnostic and Therapeutic Market by segment, 2020 & 2030 (USD Million)
• FIG 12.Global Exosome Diagnostic and Therapeutic Market by segment, 2020 & 2030 (USD Million)
• FIG 13.Global Exosome Diagnostic and Therapeutic Market by segment, 2020 & 2030 (USD Million)
• FIG 14.Global Exosome Diagnostic and Therapeutic Market, regional snapshot 2020 & 2030
• FIG 15.North America Exosome Diagnostic and Therapeutic Market 2020 & 2030 (USD Million)
• FIG 16.Europe Exosome Diagnostic and Therapeutic Market 2020 & 2030 (USD Million)
• FIG 17.Asia Pacific Exosome Diagnostic and Therapeutic Market 2020 & 2030 (USD Million)
• FIG 18.Latin America Exosome Diagnostic and Therapeutic Market 2020 & 2030 (USD Million)
• FIG 19.Middle East & Africa Exosome Diagnostic and Therapeutic Market 2020 & 2030 (USD Million)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

Global Exosome Diagnostic and Therapeutic Market is valued at approximately USD 375.64 million in 2022 and is anticipated to grow with a healthy growth rate of more than 29.4% over the forecast period 2023-2030. Exosome Diagnostic and Therapeutic refer to the use of exosomes, which are small membrane vesicles secreted by cells, for diagnostic and therapeutic purposes in various medical applications. Exosomes contain a variety of biomolecules, including proteins, nucleic acids (such as DNA, RNA, and microRNAs), lipids, and metabolites, which reflect the physiological and pathological status of their parent cells. Exosomes can serve as valuable biomarkers for the diagnosis and prognosis of various diseases. Since exosomes are released into bodily fluids like blood, urine, and saliva, they offer a non-invasive method for obtaining diagnostic information. The Exosome Diagnostic and Therapeutic market is expanding because of factors such as the increasing prevalence of chronic disease and a surge in demand for molecular diagnosis. As a result, the demand for Exosome Diagnostic and Therapeutic has progressively increased in the international market during the forecast period 2023-2030.

Chronic diseases often require early detection and continuous monitoring for effective management. Exosomes contain molecular signatures reflective of their cell of origin and carry biomolecules like proteins, nucleic acids, and lipids. By analyzing exosome content, clinicians can detect disease-specific biomarkers earlier than traditional methods, enabling timely intervention and monitoring of disease progression. According to the United Nations report, chronic diseases are anticipated to account for 70% of all global fatalities, while the global disease burden will be 56% by the year 2030. The most significant growth is expected in the African and Eastern Mediterranean regions. Furthermore, increasing understanding of exosome biology and its role in disease pathogenesis has spurred significant research and development efforts in the exosome diagnostic and therapeutic space. This includes the discovery of exosome biomarkers, the development of advanced isolation and detection techniques, and the exploration of exosome-based therapeutics. Another important factor that drives the Exosome Diagnostic and Therapeutic market is the increasing demand for molecular diagnosis. Molecular diagnosis allows for a more precise understanding of diseases at the molecular level, enabling personalized treatment strategies. Exosomes, tiny vesicles released by cells, carry valuable molecular information reflecting the status of the parent cells. By analyzing exosome contents, including proteins, nucleic acids, and lipids, molecular diagnosis facilitates the detection of specific biomarkers indicative of various diseases such as cancer, infectious diseases, and neurological disorders. In addition, as per Frontier Organization, exosomes derived from stem cells contain growth factors and signaling molecules that can stimulate cell proliferation and tissue healing. Exosome-based therapies are being explored for conditions like heart disease and tissue injuries. Moreover, the integration of advanced exosome technology in drug development and the increasing development of translational precision medicine is anticipated to create a lucrative growth opportunity for the market over the forecast period. However, the high development cost of exosome based therapeutic drugs and stringent government regulations towards drug approval are going to impede overall market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Exosome Diagnostic and Therapeutic Market study include Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the prevalence of chronic diseases in the region. According to the Centers for Disease Control and Prevention, 6 out of 10 Adults in the United States have a chronic disease. Chronic diseases often require early detection and continuous monitoring to manage effectively. Exosome-based diagnostics offer a non-invasive and sensitive method for early detection of diseases such as cancer, cardiovascular diseases, and neurological disorders. These diagnostics enable healthcare providers to intervene at earlier stages of the disease, leading to better outcomes for patients. The region's dominant performance is anticipated to propel the overall demand for Exosome Diagnostic and Therapeutic. Furthermore, Asia Pacific is expected to grow fastest during the forecast period, owing to factors such as growth in healthcare expenditures in the region. Higher healthcare spending often leads to the expansion and modernization of healthcare infrastructure, including hospitals, research facilities, and diagnostic laboratories. This expanded infrastructure can provide the necessary resources and facilities for the development, testing, and commercialization of exosome-based diagnostics and therapeutics.

Major market players included in this report are:

• Malvern Instruments Limited
• System Biosciences Incorporated
• Exiqon A/S
• Capricor Therapeutics, Inc.
• NanoSomix, Inc.
• Thermo Fisher Scientific Incorporated
• Sistemic Limited
• Exosome Diagnostic, Inc.
• NX Pharmagen, Inc.
• Aethlon Medical, Inc.

Recent Developments in the Market:

• In June 2023, Evox Therapeutics Ltd, a leading exosome therapeutics company, purchased Codiak Biosciences' engEx-AAV technology platform, including all intellectual property rights and exclusive access to certain engineering and manufacturing rights. This approach allows for active loading of adeno-associated virus into exosomes, followed by release when the AAV-loaded exosomes are transported to target cells. This is a successful method for improving AAV delivery, expanding the range of expression in pre-clinical rats, and protecting AAVs from neutralizing antibodies.

Global Exosome Diagnostic and Therapeutic Market Report Scope:

• Historical Data - 2020 - 2021
• Base Year for Estimation - 2022
• Forecast period - 2023-2030
• Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Segments Covered - Application, Product, End User, Region
• Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
• Customization Scope - Free report customization (equivalent to up to 8 analysts' working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define the market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters to detailed information about the crucial aspects such as driving factors & challenges that will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Application

• Diagnostic
• Therapeutic

By Product

• Instrument
• Reagent
• Software

By End User

• Cancer Institute
• Hospital
• Diagnostic Center
• Others

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC
• Latin America
• Brazil
• Mexico
• RoLA
• Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Table of Contents

Chapter 1.Executive Summary

• 1.1.Market Snapshot
• 1.2.Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Million)
  • 1.2.1.Exosome Diagnostic and Therapeutic Market, by Region, 2020-2030 (USD Million)
  • 1.2.2.Exosome Diagnostic and Therapeutic Market, by Application, 2020-2030 (USD Million)
  • 1.2.3.Exosome Diagnostic and Therapeutic Market, by Product, 2020-2030 (USD Million)
  • 1.2.4.Exosome Diagnostic and Therapeutic Market, by End User, 2020-2030 (USD Million)
• 1.3.Key Trends
• 1.4.Estimation Methodology
• 1.5.Research Assumption

Chapter 2.Global Exosome Diagnostic and Therapeutic Market Definition and Scope

• 2.1.Objective of the Study
• 2.2.Market Definition & Scope
  • 2.2.1.Industry Evolution
  • 2.2.2.Scope of the Study
• 2.3.Years Considered for the Study
• 2.4.Currency Conversion Rates

Chapter 3.Global Exosome Diagnostic and Therapeutic Market Dynamics

• 3.1.Exosome Diagnostic and Therapeutic Market Impact Analysis (2020-2030)
  • 3.1.1.Market Drivers
    • 3.1.1.1.Increasing Prevalence of Chronic Disease
    • 3.1.1.2.Surge In Demand for Molecular Diagnosis
  • 3.1.2.Market Challenges
    • 3.1.2.1.High Development Cost of Exosome Based Therapeutic Drugs
    • 3.1.2.2.Stringent Government Regulations on Drug Approval
  • 3.1.3.Market Opportunities
    • 3.1.3.1.Integration Of Advance Exosome Technology in Drug Development
    • 3.1.3.2.Increasing Development of Translational Precision Medicine

Chapter 4.Global Exosome Diagnostic and Therapeutic Market Industry Analysis

• 4.1.Porter's 5 Force Model
  • 4.1.1.Bargaining Power of Suppliers
  • 4.1.2.Bargaining Power of Buyers
  • 4.1.3.Threat of New Entrants
  • 4.1.4.Threat of Substitutes
  • 4.1.5.Competitive Rivalry
• 4.2.Porter's 5 Force Impact Analysis
• 4.3.PEST Analysis
  • 4.3.1.Political
  • 4.3.2.Economical
  • 4.3.3.Social
  • 4.3.4.Technological
  • 4.3.5.Environmental
  • 4.3.6.Legal
• 4.4.Top investment opportunity
• 4.5.Top winning strategies
• 4.6.COVID-19 Impact Analysis
• 4.7.Disruptive Trends
• 4.8.Industry Expert Perspective
• 4.9.Analyst Recommendation & Conclusion

Chapter 5.Global Exosome Diagnostic and Therapeutic Market, by Application

• 5.1.Market Snapshot
• 5.2.Global Exosome Diagnostic and Therapeutic Market by Application, Performance - Potential Analysis
• 5.3.Global Exosome Diagnostic and Therapeutic Market Estimates & Forecasts by Application 2020-2030 (USD Million)
• 5.4.Exosome Diagnostic and Therapeutic Market, Sub Segment Analysis
  • 5.4.1.Diagnostic
  • 5.4.2.Therapeutic

Chapter 6.Global Exosome Diagnostic and Therapeutic Market, by Product

• 6.1.Market Snapshot
• 6.2.Global Exosome Diagnostic and Therapeutic Market by Product, Performance - Potential Analysis
• 6.3.Global Exosome Diagnostic and Therapeutic Market Estimates & Forecasts by Product 2020-2030 (USD Million)
• 6.4.Exosome Diagnostic and Therapeutic Market, Sub Segment Analysis
  • 6.4.1.Instrument
  • 6.4.2.Reagent
  • 6.4.3.Software

Chapter 7.Global Exosome Diagnostic and Therapeutic Market, by End User

• 7.1.Market Snapshot
• 7.2.Global Exosome Diagnostic and Therapeutic Market by End User, Performance - Potential Analysis
• 7.3.Global Exosome Diagnostic and Therapeutic Market Estimates & Forecasts by End User 2020-2030 (USD Million)
• 7.4.Exosome Diagnostic and Therapeutic Market, Sub Segment Analysis
  • 7.4.1.Cancer Institute
  • 7.4.2.Hospital
  • 7.4.3.Diagnostic Center
  • 7.4.4.Others

Chapter 8.Global Exosome Diagnostic and Therapeutic Market, Regional Analysis

• 8.1.Top Leading Countries
• 8.2.Top Emerging Countries
• 8.3.Exosome Diagnostic and Therapeutic Market, Regional Market Snapshot
• 8.4.North America Exosome Diagnostic and Therapeutic Market
  • 8.4.1.U.S. Exosome Diagnostic and Therapeutic Market
    • 8.4.1.1.Application breakdown estimates & forecasts, 2020-2030
    • 8.4.1.2.Product breakdown estimates & forecasts, 2020-2030
    • 8.4.1.3.End User breakdown estimates & forecasts, 2020-2030
  • 8.4.2.Canada Exosome Diagnostic and Therapeutic Market
• 8.5.Europe Exosome Diagnostic and Therapeutic Market Snapshot
  • 8.5.1.U.K. Exosome Diagnostic and Therapeutic Market
  • 8.5.2.Germany Exosome Diagnostic and Therapeutic Market
  • 8.5.3.France Exosome Diagnostic and Therapeutic Market
  • 8.5.4.Spain Exosome Diagnostic and Therapeutic Market
  • 8.5.5.Italy Exosome Diagnostic and Therapeutic Market
  • 8.5.6.Rest of Europe Exosome Diagnostic and Therapeutic Market
• 8.6.Asia-Pacific Exosome Diagnostic and Therapeutic Market Snapshot
  • 8.6.1.China Exosome Diagnostic and Therapeutic Market
  • 8.6.2.India Exosome Diagnostic and Therapeutic Market
  • 8.6.3.Japan Exosome Diagnostic and Therapeutic Market
  • 8.6.4.Australia Exosome Diagnostic and Therapeutic Market
  • 8.6.5.South Korea Exosome Diagnostic and Therapeutic Market
  • 8.6.6.Rest of Asia Pacific Exosome Diagnostic and Therapeutic Market
• 8.7.Latin America Exosome Diagnostic and Therapeutic Market Snapshot
  • 8.7.1.Brazil Exosome Diagnostic and Therapeutic Market
  • 8.7.2.Mexico Exosome Diagnostic and Therapeutic Market
• 8.8.Middle East & Africa Exosome Diagnostic and Therapeutic Market
  • 8.8.1.Saudi Arabia Exosome Diagnostic and Therapeutic Market
  • 8.8.2.South Africa Exosome Diagnostic and Therapeutic Market
  • 8.8.3.Rest of Middle East & Africa Exosome Diagnostic and Therapeutic Market

Chapter 9.Competitive Intelligence

• 9.1.Key Company SWOT Analysis
• 9.2.Top Market Strategies
• 9.3.Company Profiles
  • 9.3.1.Malvern Instruments Limited
    • 9.3.1.1.Key Information
    • 9.3.1.2.Overview
    • 9.3.1.3.Financial (Subject to Data Availability)
    • 9.3.1.4.Product Summary
    • 9.3.1.5.Recent Developments
  • 9.3.2.System Biosciences Incorporated
  • 9.3.3.Exiqon A/S
  • 9.3.4.Capricor Therapeutics, Inc.
  • 9.3.5.NanoSomix, Inc.
  • 9.3.6.Thermo Fisher Scientific Incorporated
  • 9.3.7.Sistemic Limited
  • 9.3.8.Exosome Diagnostic, Inc.
  • 9.3.9.NX Pharmagen, Inc.
  • 9.3.10.Aethlon Medical, Inc

Chapter 10.Research Process

• 10.1.Research Process
  • 10.1.1.Data Mining
  • 10.1.2.Analysis
  • 10.1.3.Market Estimation
  • 10.1.4.Validation
  • 10.1.5.Publishing
• 10.2.Research Attributes
• 10.3.Research Assumption